These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29681505)

  • 1. Positive predictive value of different methods for identifying Parkinson's disease cases in an epidemiological study.
    Abbas MM; Koh WP; Tan EK; Tan LCS
    Parkinsonism Relat Disord; 2018 Sep; 54():119-120. PubMed ID: 29681505
    [No Abstract]   [Full Text] [Related]  

  • 2. Early intervention in Parkinson's disease: epidemiologic considerations.
    Tanner CM
    Ann Epidemiol; 1996 Sep; 6(5):438-41. PubMed ID: 8915475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.
    Tan LC; Koh WP; Yuan JM; Wang R; Au WL; Tan JH; Tan EK; Yu MC
    Am J Epidemiol; 2008 Mar; 167(5):553-60. PubMed ID: 18156141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary cholesterol, fats and risk of Parkinson's disease in the Singapore Chinese Health Study.
    Tan LC; Methawasin K; Tan EK; Tan JH; Au WL; Yuan JM; Koh WP
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):86-92. PubMed ID: 25669745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive testing and Parkinson's disease.
    Williams A
    Br J Hosp Med; 1991 Apr; 45(4):193. PubMed ID: 2059764
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive risk factors for chronic low back pain in Parkinson's disease.
    Ozturk EA; Kocer BG
    Clin Neurol Neurosurg; 2018 Jan; 164():190-195. PubMed ID: 29272805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Parkinson's disease in Singapore.
    Tan LC; Venketasubramanian N; Jamora RD; Heng D
    Parkinsonism Relat Disord; 2007 Feb; 13(1):40-3. PubMed ID: 17055328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and incidence of Parkinson's disease.
    Hull JT
    Geriatrics; 1970 May; 25(5):128-33. PubMed ID: 4909721
    [No Abstract]   [Full Text] [Related]  

  • 9. Case ascertainment uncertainties in prevalence surveys of Parkinson's disease.
    Anderson DW; Rocca WA; de Rijk MC; Grigoletto F; Melcon MO; Breteler MM; Maraganore DM
    Mov Disord; 1998 Jul; 13(4):626-32. PubMed ID: 9686765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How valid is the clinical diagnosis of Parkinson's disease in the community?
    Jellinger KA
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):1005-6. PubMed ID: 12810810
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic criteria of Parkinson's disease and their influence on the prevalence of this disease in population studies].
    Benito-León J; Bermejo F; Molina JA
    Neurologia; 1998 Jan; 13(1):33-9. PubMed ID: 9522581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trajectories of prediagnostic functioning in Parkinson's disease.
    Darweesh SK; Verlinden VJ; Stricker BH; Hofman A; Koudstaal PJ; Ikram MA
    Brain; 2017 Feb; 140(2):429-441. PubMed ID: 28082300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy.
    Dahodwala N; Connolly J; Farmer J; Stern MB; Jennings D; Siderowf A
    Parkinsonism Relat Disord; 2007 Dec; 13(8):495-9. PubMed ID: 17449316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and epidemiological aspects of Parkinson's disease].
    Koval'chuk AIu; Bykanova MA; Pizova NV; Kurapin EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):74-6. PubMed ID: 22433814
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterogeneity of Parkinson's disease.
    Schrag A; Quinn NP; Ben-Shlomo Y
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):275-6. PubMed ID: 16421140
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcranial ultrasound and olfaction in REM sleep behavior disorder: testing predictors of Parkinson's disease.
    Postuma RB; Montplaisir J
    Sleep Med; 2010 Apr; 11(4):339-40. PubMed ID: 20226731
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for depression in Parkinson's disease: the performance of two screening questions.
    Baillon S; Dennis M; Lo N; Lindesay J
    Age Ageing; 2014 Mar; 43(2):200-5. PubMed ID: 24132854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto M; Miyamoto T; Tatsumoto M; Watanabe Y; Suzuki S; Iwanami M; Sada T; Kadowaki T; Numao A; Trenkwalder C; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):76-81. PubMed ID: 22534309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinical profile of Parkinson's disease between Spanish and Cameroonian cohorts.
    Cubo E; Doumbe J; Martinez-Martin P; Rodriguez-Blazquez C; Kuate C; Mariscal N; Lopez I; Noubissi G; Mapoure YN; Jon JL; Mbahe S; Tchaleu B; Catalan MJ;
    J Neurol Sci; 2014 Jan; 336(1-2):122-6. PubMed ID: 24183853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.